Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated February 13, 2026, titled "Press Release on Q3 FY 2026 Results".
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vijaya Diagnostic Centre reported strong Q3 FY26 results with consolidated revenue rising 21.4% YoY to Rs 2,052.1 Mn, up from Rs 1,689.8 Mn in Q3 FY25. EBITDA grew 28.2% YoY to Rs 860.5 Mn, with margins expanding by 221 basis points to 41.9%. Profit after tax increased 22.3% YoY to Rs 431.8 Mn. For the first nine months of FY26, revenue grew 17.1% to Rs 5,948.3 Mn and PAT rose 14.8% to Rs 1,250.5 Mn. Operationally, total tests grew 14.7% and footfall rose 11.8%, with average realisation per test improving 5.9% to Rs 487. The company added new hub centres in West Bengal (Phoolbagan, Diamond Harbour) and in Khammam and Nandyal, while two earlier West Bengal hubs reached break-even within three quarters, ahead of plan.
Broadly positive for shareholders — strong double-digit revenue and profit growth, expanding margins, and healthy operational metrics signal solid business momentum. Network expansion and faster-than-expected break-even of new centres reinforce growth visibility, though the stock may already reflect high expectations given the strong print.